TY - JOUR AU - Borgquist, S. AU - Djerbi, S. AU - Ponten, F. AU - Anagnostaki, L. AU - Goldman, M. AU - Gaber, A. PY - 2008 DA - 2008// TI - HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors JO - Int J Cancer VL - 123 UR - https://doi.org/10.1002/ijc.23597 DO - 10.1002/ijc.23597 ID - Borgquist2008 ER - TY - JOUR AU - Borgquist, S. AU - Jögi, A. AU - Ponten, F. AU - Rydén, L. AU - Brennan, D. J. AU - Jirström, K. PY - 2008 DA - 2008// TI - Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer JO - Breast Cancer Res VL - 10 UR - https://doi.org/10.1186/bcr2146 DO - 10.1186/bcr2146 ID - Borgquist2008 ER - TY - JOUR AU - Brennan, D. J. AU - Laursen, H. AU - O'Connor, D. P. AU - Borgquist, S. AU - Uhlen, M. AU - Gallagher, W. M. PY - 2011 DA - 2011// TI - Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen JO - Breast Cancer Res VL - 13 UR - https://doi.org/10.1186/bcr2820 DO - 10.1186/bcr2820 ID - Brennan2011 ER - TY - JOUR AU - Goldstein, J. L. AU - Brown, M. S. PY - 1990 DA - 1990// TI - Regulation of the mevalonate pathway JO - Nature VL - 343 UR - https://doi.org/10.1038/343425a0 DO - 10.1038/343425a0 ID - Goldstein1990 ER - TY - JOUR AU - Mo, H. AU - Elson, C. E. PY - 2004 DA - 2004// TI - Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention JO - Exp Biol Med VL - 229 ID - Mo2004 ER - TY - JOUR AU - Jain, M. K. AU - Ridker, P. M. PY - 2005 DA - 2005// TI - Anti-inflammatory effects of statins: clinical evidence and basic mechanisms JO - Nat Rev Drug Discov VL - 4 UR - https://doi.org/10.1038/nrd1901 DO - 10.1038/nrd1901 ID - Jain2005 ER - TY - JOUR AU - Campbell, M. J. AU - Esserman, L. J. AU - Zhou, Y. AU - Shoemaker, M. AU - Lobo, M. AU - Borman, E. PY - 2006 DA - 2006// TI - Breast cancer growth prevention by statins JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-4061 DO - 10.1158/0008-5472.CAN-05-4061 ID - Campbell2006 ER - TY - JOUR AU - Wejde, J. AU - Blegen, H. AU - Larsson, O. PY - 1992 DA - 1992// TI - Requirement for mevalonate in the control of proliferation of human breast cancer cells JO - Anticancer Res VL - 12 ID - Wejde1992 ER - TY - JOUR AU - Wong, W. W. AU - Dimitroulakos, J. AU - Minden, M. D. AU - Penn, L. Z. PY - 2002 DA - 2002// TI - HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis JO - Leukemia VL - 16 UR - https://doi.org/10.1038/sj.leu.2402476 DO - 10.1038/sj.leu.2402476 ID - Wong2002 ER - TY - JOUR AU - Dulak, J. AU - Jozkowicz, A. PY - 2005 DA - 2005// TI - Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy JO - Curr Cancer Drug Targets VL - 5 UR - https://doi.org/10.2174/156800905774932824 DO - 10.2174/156800905774932824 ID - Dulak2005 ER - TY - JOUR AU - Friis, S. AU - Poulsen, A. H. AU - Johnsen, S. P. AU - McLaughlin, J. K. AU - Fryzek, J. P. AU - Dalton, S. O. PY - 2005 DA - 2005// TI - Cancer risk among statin users: a population-based cohort study JO - Int J Cancer VL - 114 UR - https://doi.org/10.1002/ijc.20758 DO - 10.1002/ijc.20758 ID - Friis2005 ER - TY - JOUR AU - Strandberg, T. E. AU - Pyorala, K. AU - Cook, T. J. AU - Wilhelmsen, L. AU - Faergeman, O. AU - Thorgeirsson, G. PY - 2004 DA - 2004// TI - Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S) JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)16936-5 DO - 10.1016/S0140-6736(04)16936-5 ID - Strandberg2004 ER - TY - JOUR AU - Beck, P. AU - Wysowski, D. K. AU - Downey, W. AU - Butler-Jones, D. PY - 2003 DA - 2003// TI - Statin use and the risk of breast cancer JO - J Clin Epidemiol VL - 56 UR - https://doi.org/10.1016/S0895-4356(02)00614-5 DO - 10.1016/S0895-4356(02)00614-5 ID - Beck2003 ER - TY - JOUR AU - Boudreau, D. M. AU - Yu, O. AU - Miglioretti, D. L. AU - Buist, D. S. AU - Heckbert, S. R. AU - Daling, J. R. PY - 2007 DA - 2007// TI - Statin use and breast cancer risk in a large population-based setting JO - Cancer Epidemiol Biomarkers Prev VL - 16 UR - https://doi.org/10.1158/1055-9965.EPI-06-0737 DO - 10.1158/1055-9965.EPI-06-0737 ID - Boudreau2007 ER - TY - JOUR AU - Desai, P. AU - Chlebowski, R. AU - Cauley, J. A. AU - Manson, J. E. AU - Wu, C. AU - Martin, L. W. PY - 2013 DA - 2013// TI - Prospective analysis of association between statin use and breast cancer risk in the women's health initiative JO - Cancer Epidemiol Biomarkers Prev VL - 22 UR - https://doi.org/10.1158/1055-9965.EPI-13-0562 DO - 10.1158/1055-9965.EPI-13-0562 ID - Desai2013 ER - TY - JOUR AU - Kaye, J. A. AU - Jick, H. PY - 2004 DA - 2004// TI - Statin use and cancer risk in the General Practice Research Database JO - Br J Cancer VL - 90 UR - https://doi.org/10.1038/sj.bjc.6601566 DO - 10.1038/sj.bjc.6601566 ID - Kaye2004 ER - TY - JOUR AU - Nielsen, S. F. AU - Nordestgaard, B. G. AU - Bojesen, S. E. PY - 2012 DA - 2012// TI - Statin use and reduced cancer-related mortality JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1201735 DO - 10.1056/NEJMoa1201735 ID - Nielsen2012 ER - TY - JOUR AU - Elson, C. E. AU - Peffley, D. M. AU - Hentosh, P. AU - Mo, H. PY - 1999 DA - 1999// TI - Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer JO - Exp Biol Med VL - 221 UR - https://doi.org/10.3181/00379727-221-44413 DO - 10.3181/00379727-221-44413 ID - Elson1999 ER - TY - JOUR AU - McShane, L. M. AU - Altman, D. G. AU - Sauerbrei, W. AU - Taube, S. E. AU - Gion, M. AU - Clark, G. M. PY - 2006 DA - 2006// TI - REporting recommendations for tumor MARKer prognostic studies (REMARK) JO - Breast Cancer Res Treat VL - 100 UR - https://doi.org/10.1007/s10549-006-9242-8 DO - 10.1007/s10549-006-9242-8 ID - McShane2006 ER - TY - JOUR AU - Markkula, A. AU - Hietala, M. AU - Henningson, M. AU - Ingvar, C. AU - Rose, C. AU - Jernstrom, H. PY - 2012 DA - 2012// TI - Clinical profiles predict early nonadherence to adjuvant endocrine treatment in a prospective breast cancer cohort JO - Cancer Prev Res VL - 5 UR - https://doi.org/10.1158/1940-6207.CAPR-11-0442 DO - 10.1158/1940-6207.CAPR-11-0442 ID - Markkula2012 ER - TY - JOUR AU - Simonsson, M. AU - Söderlind, V. AU - Henningson, M. AU - Hjertberg, M. AU - Rose, C. AU - Ingvar, C. PY - 2013 DA - 2013// TI - Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status JO - Cancer Causes Control VL - 24 UR - https://doi.org/10.1007/s10552-013-0169-1 DO - 10.1007/s10552-013-0169-1 ID - Simonsson2013 ER - TY - JOUR AU - Ringberg, A. AU - Bågeman, E. AU - Rose, C. AU - Ingvar, C. AU - Jernström, H. PY - 2006 DA - 2006// TI - Of cup and bra size: reply to a prospective study of breast size and premenopausal breast cancer incidence JO - Int J Cancer VL - 119 UR - https://doi.org/10.1002/ijc.22104 DO - 10.1002/ijc.22104 ID - Ringberg2006 ER - TY - JOUR AU - Markkula, A. AU - Bromee, A. AU - Henningson, M. AU - Hietala, M. AU - Ringberg, A. AU - Ingvar, C. PY - 2012 DA - 2012// TI - Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort JO - Cancer Causes Control VL - 23 UR - https://doi.org/10.1007/s10552-012-0008-9 DO - 10.1007/s10552-012-0008-9 ID - Markkula2012 ER - TY - JOUR AU - Bågeman, E. AU - Ingvar, C. AU - Rose, C. AU - Jernström, H. PY - 2008 DA - 2008// TI - Coffee consumption and CYP1A2*1 F genotype modify age at breast cancer diagnosis and estrogen receptor status JO - Cancer Epidemiol Biomarkers Prev VL - 17 UR - https://doi.org/10.1158/1055-9965.EPI-07-0555 DO - 10.1158/1055-9965.EPI-07-0555 ID - Bågeman2008 ER - TY - JOUR AU - Jernström, H. AU - Bågeman, E. AU - Rose, C. AU - Jönsson, P. E. AU - Ingvar, C. PY - 2009 DA - 2009// TI - CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients JO - Br J Cancer VL - 101 UR - https://doi.org/10.1038/sj.bjc.6605428 DO - 10.1038/sj.bjc.6605428 ID - Jernström2009 ER - TY - JOUR AU - Simonsson, M. AU - Markkula, A. AU - Bendahl, P. O. AU - Rose, C. AU - Ingvar, C. AU - Jernström, H. PY - 2014 DA - 2014// TI - Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events JO - SpringerPlus VL - 3 UR - https://doi.org/10.1186/2193-1801-3-261 DO - 10.1186/2193-1801-3-261 ID - Simonsson2014 ER - TY - STD TI - World Health Organization. BMI Classification. 2006. http://apps.who.int/bmi/index.jsp?introPage = intro_3.html Access date March 24, 2014 ID - ref27 ER - TY - JOUR AU - Lundin, K. B. AU - Henningson, M. AU - Hietala, M. AU - Ingvar, C. AU - Rose, C. AU - Jernström, H. PY - 2011 DA - 2011// TI - Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients JO - Br J Cancer VL - 105 UR - https://doi.org/10.1038/bjc.2011.441 DO - 10.1038/bjc.2011.441 ID - Lundin2011 ER - TY - JOUR AU - Rose, D. P. AU - Vona-Davis, L. PY - 2010 DA - 2010// TI - Interaction between menopausal status and obesity in affecting breast cancer risk JO - Maturitas VL - 66 UR - https://doi.org/10.1016/j.maturitas.2010.01.019 DO - 10.1016/j.maturitas.2010.01.019 ID - Rose2010 ER - TY - JOUR AU - Nelson, E. R. AU - Wardell, S. E. AU - Jasper, J. S. AU - Park, S. AU - Suchindran, S. AU - Howe, M. K. PY - 2013 DA - 2013// TI - 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology JO - Science VL - 342 UR - https://doi.org/10.1126/science.1241908 DO - 10.1126/science.1241908 ID - Nelson2013 ER - TY - JOUR AU - Warner, M. AU - Gustafsson, J. A. PY - 2014 DA - 2014// TI - On estrogen, cholesterol metabolism, and breast cancer JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMcibr1315176 DO - 10.1056/NEJMcibr1315176 ID - Warner2014 ER - TY - JOUR AU - Clendening, J. W. AU - Penn, L. Z. PY - 2012 DA - 2012// TI - Targeting tumor cell metabolism with statins JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2012.6 DO - 10.1038/onc.2012.6 ID - Clendening2012 ER - TY - JOUR AU - Kumar, A. S. AU - Benz, C. C. AU - Shim, V. AU - Minami, C. A. AU - Moore, D. H. AU - Esserman, L. J. PY - 2008 DA - 2008// TI - Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users JO - Cancer Epidemiol Biomarkers Prev VL - 17 UR - https://doi.org/10.1158/1055-9965.EPI-07-0726 DO - 10.1158/1055-9965.EPI-07-0726 ID - Kumar2008 ER - TY - JOUR AU - Osborne, C. K. AU - Yochmowitz, M. G. AU - Knight, W. A. AU - McGuire, W. L. PY - 1980 DA - 1980// TI - The value of estrogen and progesterone receptors in the treatment of breast cancer JO - Cancer VL - 46 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Osborne1980 ER - TY - JOUR AU - Bjarnadottir, O. AU - Romero, Q. AU - Bendahl, P. O. AU - Jirström, K. AU - Rydén, L. AU - Loman, N. PY - 2013 DA - 2013// TI - Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial JO - Breast Cancer Res Treat VL - 138 UR - https://doi.org/10.1007/s10549-013-2473-6 DO - 10.1007/s10549-013-2473-6 ID - Bjarnadottir2013 ER - TY - JOUR AU - Bengtsson, E. AU - Nerjovaj, P. AU - Wangefjord, S. AU - Nodin, B. AU - Eberhard, J. AU - Uhlen, M. PY - 2014 DA - 2014// TI - HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome JO - Diagn Pathol VL - 9 UR - https://doi.org/10.1186/1746-1596-9-78 DO - 10.1186/1746-1596-9-78 ID - Bengtsson2014 ER -